Abstract
Periprosthetic osteolysis remains the leading complication of total hip arthroplasty, often resulting in aseptic loosening of the implant, and a requirement for revision surgery. Wear-generated particular debris is the main cause of initiating this destructive process. The purpose of this article is to review recent advances in our understanding of how wear debris causes osteolysis, and emergent strategies for the avoidance and treatment of this disease. The most important cellular target for wear debris is the macrophage, which responds to particle challenge in two distinct ways, both of which contribute to increased bone resorption. First, it is well known that wear debris activates proinflammatory signaling, which leads to increased osteoclast recruitment and activation. More recently, it has been established that wear also inhibits the protective actions of antiosteoclastogenic cytokines such as interferon gamma, thus promoting differentiation of macrophages to bone-resorbing osteoclasts. Osteoblasts, fibroblasts, and possibly lymphocytes may also be involved in responses to wear. At a molecular level, wear particles activate MAP kinase cascades, NFκB and other transcription factors, and induce expression of suppressors of cytokine signaling. Strategies to reduce osteolysis by choosing bearing surface materials with reduced wear properties (such as metal-on-metal) should be balanced by awareness that reducing particle size may increase biological activity. Finally, although therapeutic agents against proinflammatory mediators [such as tumor necrosis factor (TNF)] and osteoclasts (bisphosphonates and molecules blocking RANKL signaling) have shown promise in animal models, no approved treatments are yet available to osteolysis patients. Considerable efforts are underway to develop such therapies, and to identify novel targets for therapeutic intervention.
Similar content being viewed by others
References
Harris WH (2001) Wear and periprosthetic osteolysis: the problem. Clin Orthop Relat Res 66–70
Dumbleton JH, Manley MT, Edidin AA (2002) A literature review of the association between wear rate and osteolysis in total hip arthroplasty. J Arthroplasty 17:649–661
Schmalzried TP, Jasty M, Harris WH (1992) Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Jt Surg Am 74:849–863
Hirakawa K, Bauer TW, Stulberg BN et al. (1996) Comparison and quantitation of wear debris of failed total hip and total knee arthroplasty. J Biomed Mater Res 31:257–263
Margevicius KJ, Bauer TW, McMahon JT et al. (1994) Isolation and characterization of debris in membranes around total joint prostheses. J Bone Jt Surg Am 76:1664–1675
Schwarz EM, Benz EB, Lu AP et al. (2000) Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res 18:849–855
Millett PJ, Allen MJ, Bostrom MP (2002) Effects of alendronate on particle-induced osteolysis in a rat model. J Bone Jt Surg Am 84-A:236–249
Merkel KD, Erdmann JM, McHugh KP et al. (1999) Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol 154:203–210
Shanbhag AS, Hasselman CT, Rubash HE (1997) The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop Relat Res:33–43
Wooley PH, Morren R, Andary J et al. (2002) Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials 23:517–526
Warme BA, Epstein NJ, Trindade MC et al. (2004) Proinflammatory mediator expression in a novel murine model of titanium-particle-induced intramedullary inflammation. J Biomed Mater Res B Appl Biomater 71:360–366
Yang SY, Wu B, Mayton L et al. (2004) Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis. Gene Ther 11:483–491
Blaine TA, Rosier RN, Puzas JE et al. (1996) Increased levels of tumor necrosis factor-alpha and interleukin-6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles. J Bone Jt Surg Am 78:1181–1192
Nakashima Y, Sun DH, Trindade MC et al. (1999) Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium–alloy particulate debris in vitro. J Bone Jt Surg Am 81:603–615
Wimhurst JA, Brooks RA, Rushton N (2001) Inflammatory responses of human primary macrophages to particulate bone cements in vitro. J Bone Jt Surg Br 83:278–282
Ingham E, Green TR, Stone MH et al. (2000) Production of TNF-alpha and bone resorbing activity by macrophages in response to different types of bone cement particles. Biomaterials 21:1005–1013
Maloney WJ, James RE, Smith RL (1996) Human macrophage response to retrieved titanium alloy particles in vitro. Clin Orthop Relat Res :268–278
Skripitz R, Aspenberg P (2000) Pressure-induced periprosthetic osteolysis: a rat model. J Orthop Res 18:481–484
Greenfield EM, Bi Y, Ragab AA et al. (2005) Does endotoxin contribute to aseptic loosening of orthopedic implants? J Biomed Mater Res B Appl Biomater 72:179–185
Saleh KJ, Thongtrangan I, Schwarz EM (2004) Osteolysis: medical and surgical approaches. Clin Orthop Relat Res:138–147
Yagil-Kelmer E, Kazmier P, Rahaman MN et al. (2004) Comparison of the response of primary human blood monocytes and the U937 human monocytic cell line to two different sizes of alumina ceramic particles. J Orthop Res 22:832–838
Xing S, Waddell JE, Boynton EL (2002) Changes in macrophage morphology and prolonged cell viability following exposure to polyethylene particulate in vitro. Microsc Res Tech 57:523–529
Chiba J, Rubash HE, Kim KJ et al (1994) The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis. Clin Orthop Relat Res:304–312
Stea S, Visentin M, Granchi D et al (2000) Cytokines and osteolysis around total hip prostheses. Cytokine 12:1575–1579
Goodman SB, Huie P, Song Y et al. (1998) Cellular profile and cytokine production at prosthetic interfaces. Study of tissues retrieved from revised hip and knee replacements. J Bone Jt Surg Br 80:531–539
Sabokbar A, Rushton N (1995) Role of inflammatory mediators and adhesion molecules in the pathogenesis of aseptic loosening in total hip arthroplasties. J Arthroplasty 10:810–816
Fiorito S, Magrini L, Goalard C (2003) Pro-inflammatory and anti-inflammatory circulating cytokines and periprosthetic osteolysis. J Bone Jt Surg Br 85:1202–1206
Granchi D, Verri E, Ciapetti G et al (1998) Bone-resorbing cytokines in serum of patients with aseptic loosening of hip prostheses. J Bone Jt Surg Br 80:912–917
Hernigou P, Intrator L, Bahrami T et al (1999) Interleukin-6 in the blood of patients with total hip arthroplasty without loosening. Clin Orthop Relat Res:147–154
Nakashima Y, Sun DH, Maloney WJ et al (1998) Induction of matrix metalloproteinase expression in human macrophages by orthopaedic particulate debris in vitro. J Bone Jt Surg Br 80:694–700
Kido A, Pap G, Nagler DK et al (2004) Protease expression in interface tissues around loose arthroplasties. Clin Orthop Relat Res:230–236
Takei I, Takagi M, Santavirta S et al (2000) Messenger ribonucleic acid expression of 16 matrix metalloproteinases in bone–implant interface tissues of loose artificial hip joints. J Biomed Mater Res 52:613–620
Sethi RK, Neavyn MJ, Rubash HE et al (2003) Macrophage response to cross-linked and conventional UHMWPE. Biomaterials 24:2561–2573
Haynes DR, Boyle SJ, Rogers SD et al (1998) Variation in cytokines induced by particles from different prosthetic materials. Clin Orthop Relat Res:223–230
Green TR, Fisher J, Stone M et al (1998) Polyethylene particles of a ‘critical size’ are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 19:2297–2302
Yang SY, Ren W, Park Y et al (2002) Diverse cellular and apoptotic responses to variant shapes of UHMWPE particles in a murine model of inflammation. Biomaterials 23:3535–3543
Shanbhag AS, Jacobs JJ, Black J et al (1994) Macrophage/particle interactions: effect of size, composition and surface area. J Biomed Mater Res 28:81–90
Brooks RA, Wimhurst JA, Rushton N (2002) Endotoxin contamination of particles produces misleading inflammatory cytokine responses from macrophages in vitro. J Bone Jt Surg Br 84:295–299
Bi Y, Van De Motter RR, Ragab AA et al (2001) Titanium particles stimulate bone resorption by inducing differentiation of murine osteoclasts. J Bone Jt Surg Am 83-A:501–508
Skoglund B, Aspenberg P (2003) PMMA particles and pressure—a study of the osteolytic properties of two agents proposed to cause prosthetic loosening. J Orthop Res 21:196–201
McEvoy A, Jeyam M, Ferrier G et al (2002) Synergistic effect of particles and cyclic pressure on cytokine production in human monocyte/macrophages: proposed role in periprosthetic osteolysis. Bone 30:171–177
Fujishiro T, Nishikawa T, Shibanuma N et al (2004) Effect of cyclic mechanical stretch and titanium particles on prostaglandin E2 production by human macrophages in vitro. J Biomed Mater Res A 68:531–536
Goodman SB, Fornasier VL, Lee J et al (1990) The histological effects of the implantation of different sizes of polyethylene particles in the rabbit tibia. J Biomed Mater Res 24:517–524
Goodman SB, Chin RC, Magee FP (1992) Prostaglandin E2 production by the membrane surrounding loose and fixated cemented tibial hemiarthroplasties in the rabbit knee. Clin Orthop Relat Res:283–287
Spector M, Shortkroff S, Hsu HP et al (1990) Tissue changes around loose prostheses. A canine model to investigate the effects of an antiinflammatory agent. Clin Orthop Relat Res:140–152
Gelb H, Schumacher HR, Cuckler J et al (1994) In vivo inflammatory response to polymethylmethacrylate particulate debris: effect of size, morphology, and surface area. J Orthop Res 12:83–92
Nagase M, Udagawa E, Schumacher HR et al (1990) Prolonged inflammatory reactions induced by ceramic powders in the rat air pouch model. Nippon Seikeigeka Gakkai Zasshi 64:602–611
Yang S, Wu B, Mayton L et al (2002) IL-1Ra and vIL-10 gene transfer using retroviral vectors ameliorates particle-associated inflammation in the murine air pouch model. Inflamm Res 51:342–350
Schwarz EM, Lu AP, Goater JJ et al (2000) Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res 18:472–480
Childs LM, Goater JJ, O'Keefe RJ et al (2001) Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 16:338–347
Carmody EE, Schwarz EM, Puzas JE et al (2002) Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles. Arthritis Rheum 46:1298–1308
Zhang X, Morham SG, Langenbach R et al (2001) Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis. J Bone Miner Res 16:660–670
Epstein NJ, Warme BA, Spanogle J et al (2005) Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation. J Orthop Res 23:501–510
Hsu H, Lacey DL, Dunstan CR et al (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:3540–3545
Nicholson GC, Malakellis M, Collier FM et al (2000) Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clin Sci (Lond) 99:133–140
Quinn JM, Elliott J, Gillespie MT et al (1998) A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139:4424–4427
Simonet WS, Lacey DL, Dunstan CR et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309–319
Hofbauer LC, Schoppet M (2004) Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292:490–495
Ulrich-Vinther M, Carmody EE, Goater JJ et al (2002) Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Jt Surg Am 84-A:1405–1412
Goater JJ, O'Keefe RJ, Rosier RN et al (2002) Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res 20:169–173
Childs LM, Paschalis EP, Xing L et al (2002) In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res 17:192–199
Masui T, Sakano S, Hasegawa Y et al (2005) Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobalt–chromium and polyethylene particles. Biomaterials 26:1695–1702
Mandelin J, Li TF, Liljestrom M et al (2003) Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone Jt Surg Br 85:1196–1201
Gehrke T, Sers C, Morawietz L et al. (2003) Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening. Scand J Rheumatol 32:287–294
Haynes DR, Crotti TN, Potter AE et al (2001) The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J Bone Jt Surg Br 83:902–911
Horiki M, Nakase T, Myoui A et al (2004) Localization of RANKL in osteolytic tissue around a loosened joint prosthesis. J Bone Miner Metab 22:346–351
Takayanagi H, Ogasawara K, Hida S et al (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408:600–605
Rakshit DS, Ly K, Sengupta TK et al (2006) Wear debris inhibition of anti-osteoclastogenic signaling By IL6 and IFN-gamma: mechanistic insights and implications for periprosthetic osteolysis. J Bone Jt Surg Am 88:788-799
Sabokbar A, Fujikawa Y, Neale S et al (1997) Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells. Ann Rheum Dis 56:414–420
Nakashima Y, Sun DH, Trindade MC et al (1999) Induction of macrophage C–C chemokine expression by titanium alloy and bone cement particles. J Bone Jt Surg Br 81:155–162
Haynes DR, Crotti TN, Zreiqat H (2004) Regulation of osteoclast activity in peri-implant tissues. Biomaterials 25:4877–4885
Yu X, Huang Y, Collin-Osdoby P et al (2004) CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res 19:2065–2077
Ishiguro N, Kojima T, Ito T et al (1997) Macrophage activation and migration in interface tissue around loosening total hip arthroplasty components. J Biomed Mater Res 35:399–406
Lassus J, Waris V, Xu JW et al (2000) Increased interleukin-8 (IL-8) expression is related to aseptic loosening of total hip replacement. Arch Orthop Trauma Surg 120:328–332
Shanbhag AS, Jacobs JJ, Black J et al (1995) Cellular mediators secreted by interfacial membranes obtained at revision total hip arthroplasty. J Arthroplasty 10:498–506
Vermes C, Chandrasekaran R, Jacobs JJ et al (2001) The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J Bone Jt Surg Am 83-A:201–211
Yao J, Cs-Szabo G, Jacobs JJ et al (1997) Suppression of osteoblast function by titanium particles. J Bone Jt Surg Am 79:107–112
Vermes C, Roebuck KA, Chandrasekaran R et al (2000) Particulate wear debris activates protein tyrosine kinases and nuclear factor kappaB, which down-regulates type I collagen synthesis in human osteoblasts. J Bone Miner Res 15:1756–1765
Pioletti DP, Leoni L, Genini D et al (2002) Gene expression analysis of osteoblastic cells contacted by orthopedic implant particles. J Biomed Mater Res 61:408–420
Zambonin G, Colucci S, Cantatore F et al (1998) Response of human osteoblasts to polymethylmetacrylate in vitro. Calcif Tissue Int 62:362–365
Wang ML, Nesti LJ, Tuli R et al (2002) Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res 20:1175–1184
Wang ML, Tuli R, Manner PA et al (2003) Direct and indirect induction of apoptosis in human mesenchymal stem cells in response to titanium particles. J Orthop Res 21:697–707
Pioletti DP, Kottelat A (2004) The influence of wear particles in the expression of osteoclastogenesis factors by osteoblasts. Biomaterials 25:5803–5808
Quinn JM, Horwood NJ, Elliott J et al (2000) Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. J Bone Miner Res 15:1459–1466
Wei X, Zhang X, Zuscik MJ et al (2005) Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles. J Bone Miner Res 20:1136–1148
Sabokbar A, Itonaga I, Sun SG et al (2005) Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening. J Orthop Res 23:511–519
Yao J, Glant TT, Lark MW et al (1995) The potential role of fibroblasts in periprosthetic osteolysis: fibroblast response to titanium particles. J Bone Miner Res 10:1417–1427
Manlapaz M, Maloney WJ, Smith RL (1996) In vitro activation of human fibroblasts by retrieved titanium alloy wear debris. J Orthop Res 14:465–472
Yaszay B, Trindade MC, Lind M et al (2001) Fibroblast expression of C–C chemokines in response to orthopaedic biomaterial particle challenge in vitro. J Orthop Res 19:970–976
Kotake S, Udagawa N, Hakoda M et al (2001) Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 44:1003–1012
Gravallese EM, Manning C, Tsay A et al (2000) Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43:250–258
Kong YY, Feige U, Sarosi I et al (1999) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304–309
Farber A, Chin R, Song Y et al (2001) Chronic antigen-specific immune-system activation may potentially be involved in the loosening of cemented acetabular components. J Biomed Mater Res 55:433–441
Arora A, Song Y, Chun L et al (2003) The role of the TH1 and TH2 immune responses in loosening and osteolysis of cemented total hip replacements. J Biomed Mater Res A 64:693–697
Baldwin L, Flanagan BF, McLaughlin PJ et al (2002) A study of tissue interface membranes from revision accord knee arthroplasty: the role of T lymphocytes. Biomaterials 23:3007–3014
Li TF, Santavirta S, Waris V et al (2001) No lymphokines in T-cells around loosened hip prostheses. Acta Orthop Scand 72:241–247
Jiranek W, Jasty M, Wang JT et al (1995) Tissue response to particulate polymethylmethacrylate in mice with various immune deficiencies. J Bone Jt Surg Am 77:1650–1661
Goodman S, Wang JS, Regula D et al (1994) T-lymphocytes are not necessary for particulate polyethylene-induced macrophage recruitment. Histologic studies of the rat tibia. Acta Orthop Scand 65:157–160
Taki N, Tatro JM, Nalepka JL et al (2005) Polyethylene and titanium particles induce osteolysis by similar, lymphocyte-independent, mechanisms. J Orthop Res 23:376–383
Sandhu J, Waddell JE, Henry M et al. (1998) The role of T cells in polyethylene particulate induced inflammation. J Rheumatol 25:1794–1799
Childs LM, Goater JJ, O'Keefe RJ et al (2001) Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis. J Bone Jt Surg Am 83-A:1789–1797
Hallab NJ, Anderson S, Stafford T et al (2005) Lymphocyte responses in patients with total hip arthroplasty. J Orthop Res 23:384–391
Davies AP, Willert HG, Campbell PA et al (2005) An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-on-metal joint replacements. J Bone Jt Surg Am 87:18–27
DeHeer DH, Engels JA, DeVries AS et al (2001) In situ complement activation by polyethylene wear debris. J Biomed Mater Res 54:12–19
Santavirta S, Hoikka V, Eskola A et al (1990) Aggressive granulomatous lesions in cementless total hip arthroplasty. J Bone Jt Surg Br 72:980–984
Palecanda A, Paulauskis J, Al-Mutairi E et al (1999) Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles. J Exp Med 189:1497–1506
Palmbos PL, Sytsma MJ, DeHeer DH et al (2002) Macrophage exposure to particulate titanium induces phosphorylation of the protein tyrosine kinase lyn and the phospholipases Cgamma-1 and Cgamma-2. J Orthop Res 20:483–489
Maloney WJ, Sun DH, Nakashima Y et al (1998) Effects of serum protein opsonization on cytokine release by titanium–alloy particles. J Biomed Mater Res 41:371–376
Sun DH, Trindade MC, Nakashima Y et al (2003) Human serum opsonization of orthopedic biomaterial particles: protein-binding and monocyte/macrophage activation in vitro. J Biomed Mater Res A 65:290–298
Rezzonico R, Chicheportiche R, Imbert V et al (2000) Engagement of CD11b and CD11c beta2 integrin by antibodies or soluble CD23 induces IL-1beta production on primary human monocytes through mitogen-activated protein kinase-dependent pathways. Blood 95:3868–3877
Rezzonico R, Imbert V, Chicheportiche R et al (2001) Ligation of CD11b and CD11c beta(2) integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta production in primary human monocytes through a pathway dependent on nuclear factor-kappaB. Blood 97:2932–2940
Abbas S, Clohisy JC, Abu-Amer Y (2003) Mitogen-activated protein (MAP) kinases mediate PMMA-induction of osteoclasts. J Orthop Res 21:1041–1048
Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337–342
Iotsova V, Caamano J, Loy J et al (1997) Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3:1285–1289
Franzoso G, Carlson L, Xing L et al (1997) Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev 11:3482–3496
Clohisy JC, Hirayama T, Frazier E et al (2004) NF-kB signaling blockade abolishes implant particle-induced osteoclastogenesis. J Orthop Res 22:13–20
Ren W, Li XH, Chen BD et al (2004) Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity. J Orthop Res 22:21–29
Miyanishi K, Trindade MC, Ma T et al (2003) Periprosthetic osteolysis: induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles. J Bone Miner Res 18:1573–1583
Shuai K, Liu B (2003) Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 3:900–911
Sengupta TK, Talbot ES, Scherle PA et al (1998) Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases. Proc Natl Acad Sci USA 95:11107–11112
Ahmed ST, Ivashkiv LB (2000) Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways. J Immunol 165:5227–5237
Kubo M, Hanada T, Yoshimura A (2003) Suppressors of cytokine signaling and immunity. Nat Immunol 4:1169–1176
Sochart DH (1999) Relationship of acetabular wear to osteolysis and loosening in total hip arthroplasty. Clin Orthop Relat Res:135–150
Ilchmann T, Markovic L, Joshi A et al (1998) Migration and wear of long-term successful Charnley total hip replacements. J Bone Jt Surg Br 80:377–381
Muratoglu OK, Bragdon CR, O'Connor DO et al (2001) A novel method of cross-linking ultra-high-molecular-weight polyethylene to improve wear, reduce oxidation, and retain mechanical properties. Recipient of the 1999 HAP Paul Award. J Arthroplasty 16:149–160
Muratoglu OK, Bragdon CR, O'Connor D et al (2001) Larger diameter femoral heads used in conjunction with a highly cross-linked ultra-high molecular weight polyethylene: a new concept. J Arthroplasty 16:24–30
Heisel C, Silva M, dela Rosa MA et al (2004) Short-term in vivo wear of cross-linked polyethylene. J Bone Jt Surg Am 86-A:748–751
Digas G, Karrholm J, Thanner J et al (2003) Highly cross-linked polyethylene in cemented THA: randomized study of 61 hips. Clin Orthop Relat Res:126–138
D'Antonio JA, Manley MT, Capello WN et al (2005) Five-year experience with Crossfire highly cross-linked polyethylene. Clin Orthop Relat Res 441:143–150
Engh CA, Sychterz CJ, Engh CA Jr (2005) Conventional ultra-high molecular weight polyethylene: a gold standard of sorts. Instr Course Lect 54:183–187
Barrack RL, Burak C, Skinner HB (2004) Concerns about ceramics in THA. Clin Orthop Relat Res:73–79
Capello WN, Dantonio JA, Feinberg JR et al (2005) Alternative bearing surfaces: alumina ceramic bearings for total hip arthroplasty. Instr Course Lect 54:171–176
Jazrawi LM, Kummer FJ, DiCesare PE (1998) Alternative bearing surfaces for total joint arthroplasty. J Am Acad Orthop Surg 6:198–203
Bourne RB, Barrack R, Rorabeck CH et al (2005) Arthroplasty options for the young patient: Oxinium on cross-linked polyethylene. Clin Orthop Relat Res 441:159–167
MacDonald SJ (2004) Metal-on-metal total hip arthroplasty: the concerns. Clin Orthop Relat Res:86–93
Cuckler JM (2005) The rationale for metal-on-metal total hip arthroplasty. Clin Orthop Relat Res 441:132–136
Pollice PF, Rosier RN, Looney RJ et al (2001) Oral pentoxifylline inhibits release of tumor necrosis factor-alpha from human peripheral blood monocytes: a potential treatment for aseptic loosening of total joint components. J Bone Jt Surg Am 83-A:1057–1061
Schwarz EM, Campbell D, Totterman S et al (2003) Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs. placebo. J Orthop Res 21:1049–1055
von Knoch M, Wedemeyer C, Pingsmann A et al (2005) The decrease of particle-induced osteolysis after a single dose of bisphosphonate. Biomaterials 26:1803–1808
von Knoch F, Heckelei A, Wedemeyer C et al (2005) The effect of simvastatin on polyethylene particle-induced osteolysis. Biomaterials 26:3549–3555
Bekker PJ, Holloway DL, Rasmussen AS et al (2005) A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. 2004. J Bone Miner Res 20:2275–2282
Takahashi N, Ozawa H (2005) A new treatment for osteoporosis using fully human monoclonal antibody to RANKL, AMG 162. Clin Calcium 15:43–48
Zwerina J, Hayer S, Tohidast-Akrad M et al (2004) Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum 50:277–290
Dai S, Hirayama T, Abbas S et al (2004) The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J Biol Chem 279:37219–37222
Bossard MJ, Tomaszek TA, Levy MA et al (1999) Mechanism of inhibition of cathepsin K by potent, selective 1,5-diacylcarbohydrazides: a new class of mechanism-based inhibitors of thiol proteases. Biochemistry 38:15893–15902
Lark MW, Stroup GB, James IE et al (2002) A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat. Bone 30:746–753
Visentin L, Dodds RA, Valente M et al (2000) A selective inhibitor of the osteoclastic V-H(+)-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats. J Clin Invest 106:309–318
Lark MW, Stroup GB, Dodds RA et al (2001) Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat. J Bone Miner Res 16:319–327
Shakespeare WC, Metcalf CA, 3rd, Wang Y et al (2003) Novel bone-targeted Src tyrosine kinase inhibitor drug discovery. Curr Opin Drug Discov Dev 6:729–741
Potter HG, Nestor BJ, Sofka CM et al (2004) Magnetic resonance imaging after total hip arthroplasty: evaluation of periprosthetic soft tissue. J Bone Jt Surg Am 86-A:1947–1954
Looney RJ, Boyd A, Totterman S et al (2002) Volumetric computerized tomography as a measurement of periprosthetic acetabular osteolysis and its correlation with wear. Arthritis Res 4:59–63
Puri L, Wixson RL, Stern SH et al (2002) Use of helical computed tomography for the assessment of acetabular osteolysis after total hip arthroplasty. J Bone Jt Surg Am 84-A:609–614
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Purdue, P.E., Koulouvaris, P., Nestor, B.J. et al. The Central Role of Wear Debris in Periprosthetic Osteolysis. HSS Jrnl 2, 102–113 (2006). https://doi.org/10.1007/s11420-006-9003-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11420-006-9003-6